Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials
Anticoagulation, reducing the risk of thromboembolic events in patients undergoing cardioversion, is a cornerstone of peri-cardioversion management in patients with atrial fibrillation. We aimed to analyse published data on the efficacy and safety of direct oral anticoagulants (DOACs) in patients u...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2017-05-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/805 |